54841 Mrv0541 02231214342D 19 20 0 0 1 0 999 V2000 3.0790 -0.2063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 -0.2063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.2063 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.5080 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6515 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 1 0 0 0 1 7 1 0 0 0 0 2 6 1 0 0 0 0 2 15 1 0 0 0 0 3 4 1 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 5 8 2 0 0 0 0 5 9 1 0 0 0 0 7 10 1 0 0 0 0 7 13 2 0 0 0 0 8 11 1 0 0 0 0 9 12 2 0 0 0 0 10 16 2 0 0 0 0 10 17 1 0 0 0 0 11 14 2 0 0 0 0 12 14 1 0 0 0 0 13 18 1 0 0 0 0 16 19 1 0 0 0 0 18 19 2 0 0 0 0 M END > T3D2737 > t3db > CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1 > InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1 > VHGCDTVCOLNTBX-QGZVFWFLSA-N > C17H21NO > 255.3547 > 255.162314299 > 2 > 29.793043055003068 > 1 > 1 > 0 > 1 > methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine > 3.95 > 3.8087924510000004 > -4.82 > 0 > 2 > 1 > 9.803139237207063 > 21.259999999999998 > 79.43500000000002 > 6 > 1 > 3.90e-03 g/l > atomoxetine > 1 > T3D2737 > Atomoxetine > 82248-59-7 > (-)-Tomoxetine; Attentin; Strattera; Tomoxetin; Tomoxetina; Tomoxetine; Tomoxetinum > Organic Compound; Amine; Ether; Drug; Central Nervous System Agent; Adrenergic Uptake Inhibitor; Antidepressant; Metabolite; Synthetic Compound; Antidepressive Agent $$$$